KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Net Income - Minority (2016 - 2024)

Bristol Myers Squibb (BMY) has disclosed Net Income - Minority for 14 consecutive years, with -$58.0 million as the latest value for Q3 2024.

  • On a quarterly basis, Net Income - Minority changed N/A to -$58.0 million in Q3 2024 year-over-year; TTM through Sep 2024 was -$58.0 million, a N/A change, with the full-year FY2023 number at -$55.0 million, changed N/A from a year prior.
  • Net Income - Minority was -$58.0 million for Q3 2024 at Bristol Myers Squibb, down from -$54.0 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of -$54.0 million in Q2 2024 to a low of -$72.0 million in Q3 2020.
  • A 4-year average of -$63.6 million and a median of -$66.0 million in 2020 define the central range for Net Income - Minority.
  • Peak YoY movement for Net Income - Minority: soared 40.0% in 2020, then fell 3.03% in 2021.
  • Bristol Myers Squibb's Net Income - Minority stood at -$60.0 million in 2020, then fell by 18.33% to -$71.0 million in 2021, then rose by 22.54% to -$55.0 million in 2023, then fell by 5.45% to -$58.0 million in 2024.
  • Per Business Quant, the three most recent readings for BMY's Net Income - Minority are -$58.0 million (Q3 2024), -$54.0 million (Q2 2024), and -$55.0 million (Q4 2023).